Literature DB >> 9510065

Intracellular transport, sorting, and proteolytic processing of regulated secretory proteins does not require protein sulfation.

F J van Kuppeveld1, A M van Horssen, G J Martens.   

Abstract

The biological significance of protein sulfation is poorly understood. To study a possible role of protein sulfation in the regulated secretory pathway, neurointermediate lobes (NIL) of the pituitary of South-African clawed toads (Xenopus laevis) were treated with chlorate, a potent in vivo inhibitor of protein sulfation. We monitored the fates of newly synthesized proopiomelanocortin (POMC), prohormone convertase (PC2), and secretogranin III (SgIII), which are sulfated and regulated secretory proteins. Inhibition of protein sulfation had no effect on the proteolytic processing of these precursor proteins and the kinetics of release of their cleavage products. The release was sensitive to apomorphine, a drug that blocks the release of proteins via the regulated secretory pathway, indicating that no missorting to the constitutive pathway had occurred. Our results suggest that protein sulfation is not required for the intracellular transport, sorting, and proteolytic processing of regulated secretory proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9510065     DOI: 10.1016/s0303-7207(97)00211-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  Sulfation of LH does not affect intracellular trafficking.

Authors:  Christopher A Pearl; Irving Boime
Journal:  Mol Cell Endocrinol       Date:  2009-03-20       Impact factor: 4.102

2.  Incomplete posttranslational prohormone modifications in hyperactive neuroendocrine cells.

Authors:  Jeroen R P M Strating; Gerard J M Martens
Journal:  BMC Cell Biol       Date:  2009-05-07       Impact factor: 4.241

3.  Disparate effects of p24alpha and p24delta on secretory protein transport and processing.

Authors:  Jeroen R P M Strating; Gerrit Bouw; Theo G M Hafmans; Gerard J M Martens
Journal:  PLoS One       Date:  2007-08-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.